DK3492089T3 - Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis - Google Patents

Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis Download PDF

Info

Publication number
DK3492089T3
DK3492089T3 DK17204458.8T DK17204458T DK3492089T3 DK 3492089 T3 DK3492089 T3 DK 3492089T3 DK 17204458 T DK17204458 T DK 17204458T DK 3492089 T3 DK3492089 T3 DK 3492089T3
Authority
DK
Denmark
Prior art keywords
composition containing
escherichia coli
enterococcus faecalis
dermatological composition
containing escherichia
Prior art date
Application number
DK17204458.8T
Other languages
English (en)
Inventor
Volker Rusch
Hans-Jörg Müller
Thomas Michael Schmidts
Kurt Zimmermann
Original Assignee
Symbiogruppe Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbiogruppe Gmbh & Co Kg filed Critical Symbiogruppe Gmbh & Co Kg
Application granted granted Critical
Publication of DK3492089T3 publication Critical patent/DK3492089T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK17204458.8T 2017-11-29 2017-11-29 Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis DK3492089T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17204458.8A EP3492089B1 (de) 2017-11-29 2017-11-29 Dermatologische zusammensetzung enthaltend escherichia coli und enterococcus faecalis

Publications (1)

Publication Number Publication Date
DK3492089T3 true DK3492089T3 (da) 2021-04-12

Family

ID=60569648

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17204458.8T DK3492089T3 (da) 2017-11-29 2017-11-29 Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis

Country Status (10)

Country Link
US (1) US10933103B2 (da)
EP (1) EP3492089B1 (da)
JP (1) JP2019099560A (da)
KR (1) KR20190063422A (da)
CN (1) CN109846907A (da)
CA (1) CA3024590A1 (da)
DK (1) DK3492089T3 (da)
ES (1) ES2861306T3 (da)
PL (1) PL3492089T3 (da)
RU (1) RU2018142254A (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11331254B2 (en) * 2018-09-25 2022-05-17 L'oreal Compositions for providing a protective barrier
JP7337551B2 (ja) * 2019-05-31 2023-09-04 株式会社ミルボン 評価方法、頭皮毛髪化粧料の選定方法、評価支援ツール、有効成分の候補物質のスクリーニング方法、頭皮毛髪化粧料の製造方法、及び、被評価者を選別するスクリーニング方法
IL293006A (en) * 2019-11-15 2022-07-01 Bruin Biometrics Llc Transepidermal water loss

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991004742A1 (en) * 1989-10-06 1991-04-18 Szabo Janos Pharmaceutical composition for the treatment of skin diseases, especially pyogenous and atopic dermatitis and process for the preparation thereof
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
FR2920307B1 (fr) * 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.

Also Published As

Publication number Publication date
ES2861306T3 (es) 2021-10-06
RU2018142254A3 (da) 2021-07-07
US10933103B2 (en) 2021-03-02
CN109846907A (zh) 2019-06-07
EP3492089A1 (de) 2019-06-05
RU2018142254A (ru) 2020-05-29
CA3024590A1 (en) 2019-05-29
PL3492089T3 (pl) 2021-08-30
JP2019099560A (ja) 2019-06-24
EP3492089B1 (de) 2021-02-17
KR20190063422A (ko) 2019-06-07
US20190160116A1 (en) 2019-05-30

Similar Documents

Publication Publication Date Title
DK3303379T3 (da) Tigit-bindende midler og anvendelser deraf
DK3357513T3 (da) Farmaceutisk sammensætning og anvendelse deraf
DK3610005T3 (da) Peptidligase og anvendelse deraf
DK3319428T3 (da) Herbicid sammensætning omfattende cinmethylin og imazamox
DK3440206T3 (da) Multimer-kodende nukleinsyre og anvendelser deraf
DK3102200T3 (da) Terapeutisk forbindelse og sammensætning
DK3514153T3 (da) Pyrimidinforbindelse og farmaceutisk anvendelse deraf
DK3372232T3 (da) Tumorterapeutisk middel omfattende gemcitabinliposomsammensætning og kit
DK3782617T3 (da) Farmaceutiske gelsammensætninger omfattende levodopa, carbidopa og entacapon
DK3255042T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning omfattende samme
DK3621694T3 (da) Lrrc33-inhibitorer og anvendelse heraf
DK3322430T3 (da) Antiinflammatoriske peptider, og anvendelser deraf
DK3548043T3 (da) Antibiotiske sammensætninger omfattende sølvioner og ebselen
DK3684855T3 (da) Kompositmateriale og dets anvendelse
IL281094A (en) Preparations containing E. Coli and their uses
DK3492089T3 (da) Dermatologisk sammensætning indeholdende Escherichia coli og Enterococcus faecalis
DK3388085T3 (da) Farmaceutisk sammensætning og anvendelser deraf
DK3947375T3 (da) Imidazolonylquinolinforbindelser og terapeutiske anvendelser deraf
DK3321279T3 (da) Exenatidmodificeringsmiddel og anvendelse deraf
DK3590523T3 (da) Vækstfremmende peptider og anvendelser deraf
DK3573611T3 (da) Amidforbindelser og anvendelse deraf
DK3512544T3 (da) Peptidforbindelser og terapeutiske anvendelser deraf
DK3302483T3 (da) Farmaceutiske sammensætninger og anvendelse deraf
DK3263133T3 (da) Pyridinonforbindelse og anvendelse deraf
DK3630112T3 (da) Kombination af regorafenib og nivolumab til behandling af cancer